The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia

被引:253
作者
Levi, M
VanderPoll, T
TenCate, H
VanDeventer, SJH
机构
[1] UNIV AMSTERDAM,ACAD MED CTR,DEPT INTERNAL MED,NL-1105 AZ AMSTERDAM,NETHERLANDS
[2] UNIV AMSTERDAM,ACAD MED CTR,EXPT MED LAB,NL-1105 AZ AMSTERDAM,NETHERLANDS
关键词
blood coagulation; cytokine; disseminated intravascular coagulation; endotoxin; fibrinolysis; lipopolysaccharide; sepsis;
D O I
10.1046/j.1365-2362.1997.570614.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Disseminated intravascular coagulation (DIC) is a frequently occurring complication of sepsis and may contribute to multiple organ failure. More insight into the pathogenesis of this derangement of the coagulation system is necessary to develop more effective therapeutic strategies for this condition. Recently, more detailed knowledge on the pathogenetic pathways involved in DIC has been obtained by the study of models of experimental bacteraemia and endotoxaemia in human subjects and non-human primates. The mechanisms that lead to activation of coagulation, potentiated by the simultaneous depression of physiological inhibitory systems and to impaired function of the fibrinolytic system, are outlined in this review. In addition, the mediatory role of various cytokines in the derangement of coagulation is discussed.
引用
收藏
页码:3 / 9
页数:7
相关论文
共 56 条
[1]  
BAUER KA, 1989, BLOOD, V74, P165
[2]   INTERLEUKIN-1 (IL-1) INDUCES BIOSYNTHESIS AND CELL-SURFACE EXPRESSION OF PROCOAGULANT ACTIVITY IN HUMAN VASCULAR ENDOTHELIAL-CELLS [J].
BEVILACQUA, MP ;
POBER, JS ;
MAJEAU, GR ;
COTRAN, RS ;
GIMBRONE, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (02) :618-623
[3]  
BIEMOND BJ, 1995, THROMB HAEMOSTASIS, V73, P223
[4]   PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 RELEASE DURING EXPERIMENTAL ENDOTOXEMIA IN CHIMPANZEES - EFFECT OF INTERVENTIONS IN THE CYTOKINE AND COAGULATION CASCADES [J].
BIEMOND, BJ ;
LEVI, M ;
TENCATE, H ;
VANDERPOLL, T ;
BULLER, HR ;
HACK, CE ;
TENCATE, JW .
CLINICAL SCIENCE, 1995, 88 (05) :587-594
[5]  
BOERMEESTER MA, 1995, ARCH SURG-CHICAGO, V130, P739
[6]   TUMOR NECROSIS FACTOR SUPPRESSES TRANSCRIPTION OF THE THROMBOMODULIN GENE IN ENDOTHELIAL-CELLS [J].
CONWAY, EM ;
ROSENBERG, RD .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (12) :5588-5592
[7]   TISSUE FACTOR PATHWAY INHIBITOR REDUCES MORTALITY FROM ESCHERICHIA-COLI SEPTIC SHOCK [J].
CREASEY, AA ;
CHANG, ACK ;
FEIGEN, L ;
WUN, TC ;
TAYLOR, FB ;
HINSHAW, LB .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) :2850-2860
[8]   INTERPLAY OF COMPLEMENT AND CYTOKINES IN THE PATHOGENESIS OF SEPTIC SHOCK [J].
DEBOER, JP ;
WOLBINK, GJ ;
THIJS, LG ;
BAARS, JW ;
WAGSTAFF, J ;
HACK, CE .
IMMUNOPHARMACOLOGY, 1992, 24 (02) :135-148
[9]   INTERLEUKIN-1 RECEPTOR BLOCKADE IMPROVES SURVIVAL AND HEMODYNAMIC PERFORMANCE IN ESCHERICHIA-COLI SEPTIC SHOCK, BUT FAILS TO ALTER HOST RESPONSES TO SUBLETHAL ENDOTOXEMIA [J].
FISCHER, E ;
MARANO, MA ;
VANZEE, KJ ;
ROCK, CS ;
HAWES, AS ;
THOMPSON, WA ;
DEFORGE, L ;
KENNEY, JS ;
REMICK, DG ;
BLOEDOW, DC ;
THOMPSON, RC ;
LOWRY, SF ;
MOLDAWER, LL .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (05) :1551-1557
[10]  
FONG Y, 1990, SURG GYNECOL OBSTET, V170, P363